ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

Trivalent Live Attenuated Vaccines for Bacterial Acute Otitis Media

Active
Institution
ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN
Principal investigator
Jason W. Rosch
Funding
$221K
Duration
2024–2026
Open portfolio

Moonbase score

Still being scored

Abstract

Summary Clinically, AOM is the leading reason for pediatrician visits and antibiotic usage by children. The predominant causative agents of AOM are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. While currently licensed capsule-based vaccines have dramatically lowered in the incidence of invasive pneumococcal disease, the incidence of mucosal infections such as AOM has remained relatively unchanged. Likewise, non-typeable H. influenzae currently predominates the AOM landscape following introduction of the Hib vaccine. Additionally complicating matters is the potential concern that a vaccine targeting an individual otopathogen may not reduce overall incidence of AOM due to the non-targeted pathogens becoming more predominant following the removal of an individual pathogen. We have engineered a safe, effective, and highly manipulatable platform for delivering protein epitopes to the mucosal surface to target multiple otopathogens simultaneously while engendering protective immunity at the mucosal surface. Leveraging a combinatorial approach for eliminating multiple AOM pathogen simultaneously using a live vaccine platform to maximize mucosal antibody responses represents a novel strategy for reducing the burden of AOM in children.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESR21Vaccines Against Infectious Diseases Study Section[VID]incidencevaccinesvaccinepneumococcalpathogenpredominantlivemucosal

Questions for ST. JUDE CHILDREN'S RESEARCH HOSPITAL

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.